GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 70 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of KREBSBIO.NS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Weaker technical forecast for Krebs Biochemicals & Industries Limited as stock downgraded to Sell Candidate.
(Updated on Apr 19, 2024)

Sell candidate since Apr 19, 2024 PDF

The Krebs Biochemicals & Industries Limited stock price fell by -3.61% on the last day (Friday, 19th Apr 2024) from ₹73.35 to ₹70.70. During the last trading day the stock fluctuated 6.20% from a day low at ₹68.50 to a day high of ₹72.75. The price has been going up and down for this period, and there has been a -2.08% loss for the last 2 weeks. Volume has increased on the last day by 3 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 6 thousand shares were bought and sold for approximately ₹437.07 thousand.

The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at ₹72.79 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -8.88% during the next 3 months and, with a 90% probability hold a price between ₹54.48 and ₹66.32 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

KREBSBIO.NS Signals & Forecast

The Krebs Biochemicals & Industries Limited stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately ₹71.16. On a fall, the stock will find some support from the long-term average at approximately ₹68.85. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, April 05, 2024, and so far it has fallen -4.27%. Further fall is indicated until a new bottom pivot has been found. Krebs Biochemicals & Industries Limited gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Krebs Biochemicals & Industries Limited stock

Krebs Biochemicals & Industries Limited finds support from accumulated volume at ₹67.70 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved ₹4.25 between high and low, or 6.20%. For the last week, the stock has had daily average volatility of 5.75%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (KREBSBIO.NS) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Krebs Biochemicals & Industries Limited to open at ₹70.65, and during the day (based on 14 day Average True Range), to move between ₹66.97 and ₹74.43, which gives a possible trading interval of +/-₹3.73 (+/-5.28%) up or down from last closing price. If Krebs Biochemicals & Industries Limited takes out the full calculated possible swing range there will be an estimated 10.56% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at ₹72.75 (2.90%) than the support at ₹67.70 (4.24%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Krebs Biochemicals & Industries Limited stock A Buy?

Krebs Biochemicals & Industries Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -1.457 Sell Candidate Downgraded

Predicted Opening Price for Krebs Biochemicals & Industries Limited of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
₹70.65 ( 0.0707%) ₹70.70

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for KREBSBIO.NS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 74.90 5.94 %
R2 73.28 3.64 %
R1 72.27 2.23 %
Current price: 70.70
Support S1 69.03 -2.37 %
S2 68.02 -3.79 %
S3 66.40 -6.08 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 74.40 5.23 %
R2 73.90 4.53 %
R1 72.75 2.90 %
Current price 70.70
Support S1 67.70 -4.24%
S2 67.00 -5.23%
S3 61.45 -13.08%

KREBSBIO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 09, 2005 Sep 14, 2005 Oct 01, 2005 ₹2.90 0%

FAQ

What is the symbol for Krebs Biochemicals & Industries Limited Stock and on which exchange is it traded?
The symbol for Krebs Biochemicals & Industries Limited is KREBSBIO.NS and it is traded on the NSE (National Stock Exchange of India).

Should I buy or sell Krebs Biochemicals & Industries Limited Stock?
Krebs Biochemicals & Industries Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy Krebs Biochemicals & Industries Limited Stock?
Krebs Biochemicals & Industries Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Krebs Biochemicals & Industries Limited Stock.

What's the current price of Krebs Biochemicals & Industries Limited Stock?
As of the end of day on the 2024-04-19, the price of an Krebs Biochemicals & Industries Limited (KREBSBIO.NS) share was ₹70.70.

What is the 52-week high and low for Krebs Biochemicals & Industries Limited Stock?
The 52-week high for Krebs Biochemicals & Industries Limited Stock is ₹93.95 and the 52-week low is ₹59.20.

What is the market capitalization of Krebs Biochemicals & Industries Limited Stock?
As of the 2024-04-19, the market capitalization of Krebs Biochemicals & Industries Limited is 1.581B.

When is the next earnings date for Krebs Biochemicals & Industries Limited?
The upcoming earnings date for Krebs Biochemicals & Industries Limited is May 22, 2024.
Click to get the best stock tips daily for free!

About Krebs Biochemicals & Industries Limited

Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, t... KREBSBIO.NS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT